S Y Tse
Chief Executive Officer en SINO BIOPHARMACEUTICAL LIMITED .
Fortuna: 1 619 M $ al 29/02/2024
Perfil
S Y Tse forma parte del consejo de administración de Sino Biopharmaceutical Ltd. S Y Tse se licenció en la Wharton School de la Universidad de Pensilvania y se graduó en el Schwarzman College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/12/2022 | 4 050 000 000 ( 21.54% ) | 1 619 M $ | 29/02/2024 |
Cargos activos de S Y Tse
Empresas | Cargo | Inicio |
---|---|---|
SINO BIOPHARMACEUTICAL LIMITED | Chief Executive Officer | 28/07/2022 |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Director/Board Member | 10/11/2020 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Chairman | 30/07/2020 |
Antiguos cargos conocidos de S Y Tse.
Empresas | Cargo | Fin |
---|---|---|
Liepin North America, Inc. | Chief Executive Officer | - |
Formación de S Y Tse.
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Schwarzman College | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
Empresas privadas | 3 |
---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Health Technology |
Liepin North America, Inc. |